A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company Grifols against short seller Gotham City Research, Grifols said in a statement on ...

Grifols (GFRS) has marked a major win in its legal battle against Gotham City Research after a New York federal court declined a request made by the hedge fund seeking a dismissal of a defamation ...

U.S. court lets Grifols sue Gotham City for defamation over short report, but dismisses most claims in major financial free ...

Gotham report noted that Grifols claimed to address all the questions, yet new information from Kepler note suggests otherwise. Gotham said Grifols' representation of the lending activity was ...

Spanish drugmaker Grifols has hit back at hedge fund Gotham City Research, which claimed it had fraudulently manipulated its financial reporting, with a lawsuit filed in New York. The complaint ...

Adds reaction from Grifols in paragraphs 3, Gotham's allegations in paragraph 9, supervisor probe in final paragraph MADRID, Feb 20 (Reuters) - Short-seller fund Gotham City Research on Tuesday ...

BARCELONA, Jan 10 (Reuters) - Spain's pharmaceutical company Grifols will seek a compensation at least equivalent to the share price loss prompted by short seller Gotham City Research's Tuesday ...

The owner of Gotham City Research LLC wasted no time slashing its bet against Grifols SA after the short seller’s report sparked a record plunge in the company’s stock. The same day Grifols ...

Gotham City's recent allegations against Grifols have caused GFRS stock to significantly decline. Our team at Mare will remain waiting for clarifications. We expect the company's stock to be under ...

Grifols SA shares fell after short-seller Gotham City Research released a new report accusing the healthcare company of transferring funds from its shareholders to a vehicle held by former executives.